Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series
Low-dose RTX followed by MMF can extend the remission duration of FRNS/SDNS in children, and decrease the economic burden on families, while offering good safety.
Authors
- Jingdong Song (ORCID: https://orcid.org/0000-0001-8808-1981)
- Nana Nie
- Jia Liu (ORCID: https://orcid.org/0000-0002-2845-1028)
- Bai Cui
- Chunrong Shan
- Yi Lin (ORCID: https://orcid.org/0000-0002-7194-5023)
- Hong Chang (ORCID: https://orcid.org/0000-0002-1318-0624)
- Shan Gao (ORCID: https://orcid.org/0000-0001-6370-4994)
- Ranran Zhang (ORCID: https://orcid.org/0000-0002-5273-3615)
- Dahai Wang (ORCID: https://orcid.org/0000-0001-5488-4831)
- Qiuye Zhang
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Qingdao Women and Children's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.3389/fphar.2025.1646837
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- Qingdao University